List view / Grid view
30 April 2015 | By Victoria White
Genocea's GEN-003 is better positioned to compete in the future genital herpes treatment space, despite being slightly behind Agenus’ HerpV in development...
30 April 2015 | By Victoria White
WHO has taken leadership in coordinating medical relief for communities affected by Saturday's devastating earthquake in Nepal...
30 April 2015 | By Victoria White
Professor Alan Boyd, owner of Boyds consultancy business, has been elected as President of the Faculty of Pharmaceutical Medicine...
30 April 2015 | By Victoria White
The market value for prostate cancer will expand more than threefold to an estimated $8.2 billion by 2023, driven by the label extension of Xtandi...
30 April 2015 | By Victoria White
Martindale Pharma today announced the appointment of AFT Pharmaceuticals as its distribution partner for several Asia Pacific markets...
30 April 2015 | By Victoria White
The European Society of Clinical Microbiology and Infectious Disease announced a live update on breaking science emerging at its annual congress, ECCMID...
30 April 2015 | By Victoria White
The FDA will review data supporting Amgen’s Biologics License Application (BLA) for Repatha (evolocumab) for the treatment of high cholesterol...
30 April 2015 | By Victoria White
CoLucid Pharmaceuticals has announced that the first patient has been randomised in its SAMURAI study, the Company’s Phase 3 pivotal trial of lasmiditan...
30 April 2015 | By Victoria White
The FDA has accepted for filing and review the sBLA for Opdivo for the treatment of previously untreated patients with unresectable or metastatic melanoma...
29 April 2015 | By kdm communications
Glass Solutions has launched a range of jacketed reactor systems combining excellent value with reliable performance for process development, reaction optimization, or production applications...
29 April 2015 | By Victoria White
amp biosimilars has announced Professor Dr Rolf G. Werner is to head up the Scientific Board as "Chairman of the Scientific Board", effective immediately...
29 April 2015 | By Victoria White
The FDA has granted Fast Track designation for the development of Genzyme’s GZ/SAR402671, an investigational substrate reduction therapy for Fabry disease...
29 April 2015 | By Victoria White
Results from Phase 3 clinical studies of Zerbaxa in complicated urinary tract infections and complicated intra-abdominal infections have been published...
29 April 2015 | By Victoria White
The EC has granted marketing authorisation in Europe for Sanofi’s Toujeo for the treatment of type 1 and type 2 diabetes mellitus in adults...
29 April 2015 | By Victoria White
A survey has revealed there are major gaps in actions needed across all six WHO regions to reduce spread of antibiotic resistance...
